114 results for "Spike Proteins and Enzymes" in Products
Spike Proteins and Enzymes
R&D Systems offers high-quality Spike proteins, rigorously validated for consistency and bioactivity. Our Spike proteins have been cited in 166 publications with 13 5-star customer reviews. These proteins are reactive in BatCoV RaTG13, HCoV-OC43, MERS-CoV, SARS-CoV, and SARS-CoV-2.
These proteins, untagged or featuring a Fc, His, Flag, or Avi tag, are produced using multiple host expression systems to accommodate diverse research needs..
Choose Spike proteins best suited for your research ...
Ectodomain, Stabilized Prefusion Conformation, Resistant to Furin Cleavage
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Omicron variant
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Delta Variant (India) His-tag
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
GCN4-IZ trimerization domain, Stabilized Prefusion Conformation, Resistant to Furin Cleavage
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
(1-1273 4x aa mut.)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV |
| Source: | HEK293 |
| Accession #: | P59594.1 |
| Applications: | Bioactivity |
Beta Variant (South Africa)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Gamma Variant (Brazil)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
L452R T478K Delta Variant (India)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Omicron Variant His-tag
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK) Resistant to Furin & Stabilized Prefusion Conformation
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
His-tag Kappa Variant (India)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Omnicron Variant
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
CHO Expressed, 4 Point Mutations
| Reactivity: | SARS-CoV-2 |
| Source: | CHO |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
5 Point Mutations (D614G, R682S, R685S, K986P, V987P)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
CHO Expressed His-tag. Mutations: D614G, R682S, R685S, K986P, V987P
| Reactivity: | SARS-CoV-2 |
| Source: | CHO |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | BatCoV RaTG13 |
| Source: | CHO |
| Accession #: | QHR63300.2 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
D614G, Q677H
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
W152C, L452R, D614G
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Beta Variant (South Africa)
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK) with E484K Point Mutation. His-tag.
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
Alpha Variant (UK) with S494P Mutation. His-tag
| Reactivity: | SARS-CoV-2 |
| Source: | HEK293 |
| Accession #: | YP_009724390.1 |
| Applications: | Bioactivity |
